本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Assertio Holdings, Inc.

0.7880
+0.00770.99%
盤後0.79030.0023+0.29%19:09 EST
成交量:24.77萬
成交額:19.27萬
市值:7,584.66萬
市盈率:-2.61
高:0.7880
開:0.7505
低:0.7450
收:0.7803
52周最高:1.04
52周最低:0.5137
股本:9,625.21萬
流通股本:8,517.00萬
量比:0.80
換手率:0.29%
股息:- -
股息率:- -
每股收益(TTM):-0.3018
每股收益(LYR):-0.2265
淨資產收益率:-24.48%
總資產收益率:-4.17%
市淨率:0.72
市盈率(LYR):-3.48

資料載入中...

公司資料

公司名字:
Assertio Holdings, Inc.
交易所:
NASDAQ
成立時間:
2020
員工人數:
58
公司地址:
100 South Saunders Road,Suite 300,Lake Forest,Illinois,United States
郵編:
60045
電話:
傳真:
510 744 8001
簡介:
Assertio Holdings, Inc.是一家領先的多元化,商業製藥公司,專註於為需要的患者提供增強治療選擇的獨特產品。2020年5月19日,Assertio根據合併協議和計劃實施了Assertio重組。Assertio Therapeutics是Assertio Holdings的全資子公司。

董事

名稱
職位
Mark L. Reisenauer
Director and Chief Executive Officer
Brendan P. O'Grady
Director
David M. Stark
Director
Heather L. Mason
Director
Sigurd C. Kirk
Director
Sravan K. Emany
Director
William T. McKee
Director

股東

名稱
職位
Mark L. Reisenauer
Director and Chief Executive Officer
Paul Schwichtenberg
President and Chief Operating Officer
Ajay Patel
Executive Vice President and Chief Financial Officer
Mary E. Pietryga
Executive Vice President and Chief Commercial Officer
Sam Schlessinger
Executive Vice President and General Counsel